explore -WSS

explore

author：fashion 2025-10-02 00:18:43 - browse：6879

Photo illustration of Fyodor Urnov surrounded by DNA strands. -- health coverage from STAT — Christine Kao/STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing.

Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates. “Anyone who would listen,” he says.

The problem was one of scale. Sure, for-profit companies were developing cures for a small handful of genetic diseases, such as sickle cell disease. But there were hundreds of devastating conditions that CRISPR might be able to cure but that no entity was seriously working on.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

WSS

Trump indictment: Who are the 'co

Latigo launches with $135 million for Vertex

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Physician groups backed by private equity giant lobby on mergers

Having children helps parents live longer, especially after age 80

Wikipedia

explore

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

What the US credit downgrade means for the economy, your finances

23andMe had bad news about my health. I wish a person had delivered it

Congress must protect the remaining independent doctors

Tori Bowie and the unacceptable rates of Black maternal death

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

23andMe had bad news about my health. I wish a person had delivered it

Why don't Americans have at

Wildfire smoke exposes gaps in outdoor worker protections

Mega Millions pot grows to $1.25 billion after no winner

focus

5 important ways Henrietta Lacks changed medical science

EQRx, failed developer of low

Here’s what’s in the FDA plan to include pregnant women in clinical trials

STAT Boddities: What happens to the brain when we get scared?

Bernie Sanders gets little from pharma CEOs on drug prices

Mega Millions pot grows to $1.25 billion after no winner

leisure time

focus

hotspot

leisure time